{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T10:44:39Z","timestamp":1751539479869},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,3,3]],"date-time":"2015-03-03T00:00:00Z","timestamp":1425340800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,3,3]],"date-time":"2015-03-03T00:00:00Z","timestamp":1425340800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Drugs"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1007\/s40272-015-0123-7","type":"journal-article","created":{"date-parts":[[2015,3,2]],"date-time":"2015-03-02T14:12:36Z","timestamp":1425305556000},"page":"167-174","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Measles\u2013Mumps\u2013Rubella\u2013Varicella Combination Vaccine (ProQuad\u00ae): A Guide to Its Use in Children in the EU"],"prefix":"10.1007","volume":"17","author":[{"given":"Lesley J.","family":"Scott","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,3,3]]},"reference":[{"key":"123_CR1","unstructured":"WHO, UNICEF, World Bank. State of the world\u2019s vaccines and immunization, 3rd ed. Geneva: World Health Organization; 2009."},{"key":"123_CR2","unstructured":"World Health Organization. European vaccine action plan 2015\u20132020. 2014. http:\/\/www.euro.who.int. Accessed 22 Dec 2014."},{"issue":"22","key":"123_CR3","doi-asserted-by":"crossref","first-page":"20183","DOI":"10.2807\/ese.17.22.20183-en","volume":"17","author":"M Haverkate","year":"2012","unstructured":"Haverkate M, D\u2019Ancona F, Giambi C, et al. Mandatory and recommended vaccination in the EU, Iceland and Norway: results of the VENICE 2012 survey on ways of implementing national vaccination programmes. Euro Surveill. 2012;17(22):20183.","journal-title":"Euro Surveill."},{"key":"123_CR4","unstructured":"European Centre for Disease Prevention and Control. ECDC technical report. Measles and rubella elimination: communicating the importance of vaccination. 2014. http:\/\/ecdc.europa.eu. Accessed 2 Feb 2015."},{"key":"123_CR5","unstructured":"European Centre for Disease Prevention and Control. ECDC preliminary guidance: varicella vaccine in the European Union. 2014. http:\/\/www.ecdc.europa.eu. Accessed 2 Feb 2015."},{"key":"123_CR6","unstructured":"Marin M, G\u00fcris D, Chaves SS, et al. Prevention of varicella: recommendations of the Advisory Committees on Immunization Practices (ACIP). 2007. http:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/rr5604a1.htm. Accessed 16 Feb 2015."},{"issue":"7","key":"123_CR7","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1097\/INF.0b013e3180616c8f","volume":"26","author":"T Vesikari","year":"2007","unstructured":"Vesikari T, Sadzot-Delvaux C, Rentier B, et al. Increasing coverage and efficiency for measles, mumps, and rubella vaccine and introducing universal varicella vaccination in Europe: a role for a combined vaccine. Pediatr Infect Dis J. 2007;26(7):632\u20138.","journal-title":"Pediatr Infect Dis J."},{"issue":"Suppl 2","key":"123_CR8","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1016\/S1201-9712(07)60022-8","volume":"11","author":"J Ramet","year":"2007","unstructured":"Ramet J. A new challenge for Europe: introducing a pediatric quadrivalent vaccine for measles, mumps, rubella, and varicella. Int J Infect Dis. 2007;11(Suppl 2):S49\u201355.","journal-title":"Int J Infect Dis."},{"key":"123_CR9","unstructured":"World Health Organization. WHO recommendations for routine immunization\u2014summary tables.\u00a02012. http:\/\/www.who.int\/immunization\/policy\/immunization_tables\/en\/. Accessed 8 Dec 2012."},{"issue":"12","key":"123_CR10","first-page":"e440","volume":"18","author":"BK Ackerson","year":"2012","unstructured":"Ackerson BK, Sy LS, Cheetham TC, et al. Impact of MMRV combination vaccine on childhood vaccination compliance. Am J Manag Care. 2012;18(12):e440\u20135.","journal-title":"Am J Manag Care."},{"key":"123_CR11","unstructured":"European Medicines Agency. Summary of product characteristics: ProQuad powder and solvent for suspension for injection. 2011. http:\/\/www.ema.europa.eu. Accessed 16 Dec 2014."},{"issue":"20","key":"123_CR12","doi-asserted-by":"publisher","first-page":"3082","DOI":"10.1016\/j.vaccine.2012.02.062","volume":"30","author":"T Vesikari","year":"2012","unstructured":"Vesikari T, Becker T, Gajdos V, et al. Immunogenicity and safety of a two-dose regimen of a combined measles, mumps, rubella and varicella live vaccine (ProQuad\u00ae) in infants from 9 months of age. Vaccine. 2012;30(20):3082\u20139.","journal-title":"Vaccine."},{"issue":"8","key":"123_CR13","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1097\/01.inf.0000172901.29621.e9","volume":"24","author":"H Shinefield","year":"2005","unstructured":"Shinefield H, Black S, Williams WR, et al. Dose-response study of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children. Pediatr Infect Dis J. 2005;24(8):670\u20135.","journal-title":"Pediatr Infect Dis J."},{"issue":"8","key":"123_CR14","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1097\/01.inf.0000172902.25009.a1","volume":"24","author":"H Shinefield","year":"2005","unstructured":"Shinefield H, Black S, Digilio L, et al. Evaluation of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children. Pediatr Infect Dis J. 2005;24(8):665\u20139.","journal-title":"Pediatr Infect Dis J."},{"issue":"7","key":"123_CR15","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1097\/01.inf.0000220209.35074.0b","volume":"25","author":"JM Lieberman","year":"2006","unstructured":"Lieberman JM, Williams WR, Miller JM, et al. The safety and immunogenicity of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children: a study of manufacturing consistency and persistence of antibody. Pediatr Infect Dis J. 2006;25(7):615\u201322.","journal-title":"Pediatr Infect Dis J."},{"issue":"4","key":"123_CR16","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1097\/01.inf.0000207857.10947.1f","volume":"25","author":"H Shinefield","year":"2006","unstructured":"Shinefield H, Black S, Thear M, et al. Safety and immunogenicity of a measles, mumps, rubella and varicella vaccine given with combined Haemophilus influenzae type b conjugate\/hepatitis B vaccines and combined diphtheria-tetanus-acellular pertussis vaccines. Pediatr Infect Dis J. 2006;25(4):287\u201392.","journal-title":"Pediatr Infect Dis J."},{"issue":"2","key":"123_CR17","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1542\/peds.2005-0092","volume":"117","author":"KS Reisinger","year":"2006","unstructured":"Reisinger KS, Brown ML, Xu J, et al. A combination measles, mumps, rubella, and varicella vaccine (ProQuad) given to 4- to 6-year-old healthy children vaccinated previously with M\u2013M\u2013RII and Varivax. Pediatrics. 2006;117(2):265\u201372.","journal-title":"Pediatrics."},{"issue":"5","key":"123_CR18","doi-asserted-by":"publisher","first-page":"205","DOI":"10.4161\/hv.2.5.3246","volume":"2","author":"BJ Kuter","year":"2006","unstructured":"Kuter BJ, Brown ML, Hartzel J, et al. Safety and immunogenicity of a combination measles, mumps, rubella and varicella vaccine (ProQuad\u00ae). Hum Vaccin. 2006;2(5):205\u201314.","journal-title":"Hum Vaccin."},{"issue":"6","key":"123_CR19","doi-asserted-by":"publisher","first-page":"e1299","DOI":"10.1542\/peds.2006-2283","volume":"119","author":"HH Bernstein","year":"2007","unstructured":"Bernstein HH, Eves K, Campbell K, et al. Comparison of the safety and immunogenicity of a refrigerator-stable versus a frozen formulation of ProQuad (measles, mumps, rubella, and varicella virus vaccine live). Pediatrics. 2007;119(6):e1299\u2013305.","journal-title":"Pediatrics."},{"issue":"8","key":"123_CR20","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.4161\/hv.24873","volume":"9","author":"RJ Yetman","year":"2013","unstructured":"Yetman RJ, Shepard JS, Duke A, et al. Concomitant administration of hepatitis A vaccine with measles\/mumps\/rubella\/varicella and pneumococcal vaccines in healthy 12- to 23-month-old children. Hum Vaccin Immunother. 2013;9(8):1691\u20137.","journal-title":"Hum Vaccin Immunother."},{"issue":"6","key":"123_CR21","doi-asserted-by":"publisher","first-page":"e1387","DOI":"10.1542\/peds.2010-2132","volume":"128","author":"M Leonardi","year":"2011","unstructured":"Leonardi M, Bromberg K, Baxter R, et al. Immunogenicity and safety of MMRV and PCV-7 administered concomitantly in healthy children. Pediatrics. 2011;128(6):e1387\u201394.","journal-title":"Pediatrics."},{"issue":"8","key":"123_CR22","doi-asserted-by":"publisher","first-page":"e133","DOI":"10.1097\/INF.0b013e318259fc8a","volume":"31","author":"MM Blatter","year":"2012","unstructured":"Blatter MM, Klein NP, Shepard JS, et al. Immunogenicity and safety of two tetravalent (measles, mumps, rubella, varicella) vaccines coadministered with hepatitis A and pneumococcal conjugate vaccines to children twelve to fourteen months of age. Pediatr Infect Dis J. 2012;31(8):e133\u201340.","journal-title":"Pediatr Infect Dis J."},{"issue":"26","key":"123_CR23","doi-asserted-by":"publisher","first-page":"3929","DOI":"10.1016\/j.vaccine.2012.03.080","volume":"30","author":"NP Klein","year":"2012","unstructured":"Klein NP, Shepard J, Bedell L, et al. Immunogenicity and safety of a quadrivalent meningococcal conjugate vaccine administered concomitantly with measles, mumps, rubella, varicella vaccine in healthy toddlers. Vaccine. 2012;30(26):3929\u201336.","journal-title":"Vaccine."},{"issue":"52","key":"123_CR24","doi-asserted-by":"publisher","first-page":"7154","DOI":"10.1016\/j.vaccine.2014.08.067","volume":"32","author":"SO Klopfer","year":"2014","unstructured":"Klopfer SO, Stek JE, Petrecz M, et al. Analysis of safety data in children after receiving two doses of ProQuad\u00ae (MMRV). Vaccine. 2014;32(52):7154\u201360.","journal-title":"Vaccine."},{"issue":"6","key":"123_CR25","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.vaccine.2013.12.011","volume":"32","author":"T Schink","year":"2014","unstructured":"Schink T, Holstiege J, Kowalzik F, et al. Risk of febrile convulsions after MMRV vaccination in comparison to MMR or MMR+V vaccination. Vaccine. 2014;32(6):645\u201350.","journal-title":"Vaccine."},{"issue":"1","key":"123_CR26","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1542\/peds.2010-0665","volume":"126","author":"NP Klein","year":"2010","unstructured":"Klein NP, Fireman B, Yih WK, et al. Measles\u2013mumps\u2013rubella\u2013varicella combination vaccine and the risk of febrile seizures. Pediatrics. 2010;126(1):e1\u20138.","journal-title":"Pediatrics."},{"issue":"5","key":"123_CR27","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1542\/peds.2011-3198","volume":"129","author":"NP Klein","year":"2012","unstructured":"Klein NP, Lewis E, Baxter R, et al. Measles\u2013containing vaccines and febrile seizures in children age 4 to 6\u00a0years. Pediatrics. 2012;129(5):809\u201314.","journal-title":"Pediatrics."},{"issue":"34","key":"123_CR28","doi-asserted-by":"publisher","first-page":"4656","DOI":"10.1016\/j.vaccine.2009.05.056","volume":"27","author":"SJ Jacobsen","year":"2009","unstructured":"Jacobsen SJ, Ackerson BK, Sy LS, et al. Observational safety study of febrile convulsion following first dose MMRV vaccination in a managed care setting. Vaccine. 2009;27(34):4656\u201361.","journal-title":"Vaccine."},{"issue":"11","key":"123_CR29","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1503\/cmaj.140078","volume":"186","author":"SE MacDonald","year":"2014","unstructured":"MacDonald SE, Dover DC, Simmonds KA, et al. Risk of febrile seizures after first dose of measles\u2013mumps\u2013rubella\u2013varicella vaccine: a population-based cohort study. CMAJ. 2014;186(11):824\u20139.","journal-title":"CMAJ."}],"container-title":["Pediatric Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-015-0123-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40272-015-0123-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-015-0123-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-015-0123-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T16:23:28Z","timestamp":1659111808000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40272-015-0123-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,3]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["123"],"URL":"https:\/\/doi.org\/10.1007\/s40272-015-0123-7","relation":{},"ISSN":["1174-5878","1179-2019"],"issn-type":[{"value":"1174-5878","type":"print"},{"value":"1179-2019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,3]]},"assertion":[{"value":"3 March 2015","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}